Alexion Pharmaceuticals, Inc.

Candriam S.C.A. ALXN

Report date

6/30/2021

Quarter

2021 Q2

Filed

7/20/2021

Shares

503,510

Value ($000)

92,500

Weight

0.6%

2019 Q3 - 2021 Q2 (8 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	7/20/2021	92,500	0.6%	503,510	6/30/2021
2021 Q1	4/29/2021	91,590	0.8%	610,282	3/31/2021
2020 Q4	1/22/2021	95,354	0.8%	610,282	12/31/2020
2020 Q3	10/19/2020	64,430	0.6%	563,072	9/30/2020
2020 Q2	7/23/2020	63,317	0.7%	564,099	6/30/2020
2020 Q1	5/26/2020	60,874	0.7%	575,794	3/31/2020
2019 Q4	2/5/2020	62,272	0.7%	575,794	12/31/2019
2019 Q3	2/5/2020	61,875	0.8%	631,766	9/30/2019